Kidopia Ophthalmic Solution

An alkaloid, originally from Atropa belladonna, but found in other plants, mainly solanaceae.

Atropine is a muscarinic antagonist used to treat poisoning by muscarinic agents, including organophosphates and other drugs.

For the treatment of poisoning by susceptible organophosphorous nerve agents having anti-cholinesterase activity (cholinesterase inhibitors) as well as organophosphorous or carbamate insecticides.

• Amblyopia
• Atrioventricular Heart Block
• Bradycardia
• Bronchospasm
• Crying
• Detrusor Hyperreflexia
• Excessive bronchial secretion
• Hypertonic uterine contraction
• Hypertonicity of the small intestine
• Ocular Inflammation
• Parkinsonism
• Peptic Ulcer
• Poisoning by parasympathomimetics (cholinergics)
• Poisoning caused by mushrooms
• Poisoning caused by organophosphate anticholinesterase nerve agents
• Poisoning caused by organophosphorus pesticides
• Pylorospasm
• Rhinorrhoea
• Sinus Bradycardia
• Spasms
• Toxic effect of organophosphate and carbamate
• Hypermobility of the colon
• Laughing
• Muscarinic side effects

Atropine, a naturally occurring belladonna alkaloid, is a racemic mixture of equal parts of d- and l-hyoscyamine, whose activity is due almost entirely to the levo isomer of the drug. Atropine is commonly classified as an anticholinergic or antiparasympathetic (parasympatholytic) drug. More precisely, however, it is termed an antimuscarinic agent since it antagonizes the muscarine-like actions of acetylcholine and other choline esters. Adequate doses of atropine abolish various types of reflex vagal cardiac slowing or asystole. The drug also prevents or abolishes bradycardia or asystole produced by injection of choline esters, anticholinesterase agents or other parasympathomimetic drugs, and cardiac arrest produced by stimulation of the vagus. Atropine may also lessen the degree of partial heart block when vagal activity is an etiologic factor. Atropine in clinical doses counteracts the peripheral dilatation and abrupt decrease in blood pressure produced by choline esters. However, when given by itself, atropine does not exert a striking or uniform effect on blood vessels or blood pressure.

Atropine binds to and inhibit muscarinic acetylcholine receptors, producing a wide range of anticholinergic effects.

Atropine is rapidly and well absorbed after intramuscular administration. Atropine disappears rapidly from the blood and is distributed throughout the various body tissues and fluids.

The protein binding of atropine is 14 to 22% in plasma.

Much of the drug is destroyed by enzymatic hydrolysis, particularly in the liver; from 13 to 50% is excreted unchanged in the urine.

3.0 ± 0.9 hours in adults. The half-life of atropine is slightly shorter (approximately 20 minutes) in females than males.

Oral, mouse: LD₅₀ = 75 mg/kg. Symptoms of overdose includes widespread paralysis of parasympathetically innervated organs. Dry mucous membranes, widely dilated and nonresponsive pupils, tachycardia, fever and cutaneous flush are especially prominent, as are mental and neurological symptoms. In instances of severe intoxication, respiratory depression, coma, circulatory collapse and death may occur.

• Avoid alcohol.
• Take with food.

• Dog & Cat: 1 ml/25 kg body weight subcutaneously.
• Sheep/Goat: 1 ml/5 kg body weight intravenously.

• Cattle/Horse: 1.5-3.0 ml/50 kg body weight.
• Sheep/Goat: 0.8-1.6 ml/10 kg body weight.
• Dog/Cat: 0.3-0.5 ml/10 kg body weight
• Pigs: 0.2-0.4 ml/10 kg body weight.